BURTON CROFT SURGERY — All Prescriptions & Medications — Page 7
Practice Code: B86030 | LEEDS, LS6 2AF
Showing results 301-350 of 574
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Permethrin | 57 | 4,980 | £1.6K | +51.3% ▲ |
| Methyldopa | 55 | 1,792 | £1.6K | +222.9% ▲ |
| Trospium chloride | 55 | 3,584 | £2.0K | +7.7% ▲ |
| Tamoxifen citrate | 55 | 2,884 | £249 | -33.2% ▼ |
| Neomycin sulfate | 54 | 870 | £110 | -8.9% ▼ |
| Metronidazole | 54 | 2,270 | £885 | +43.7% ▲ |
| Zinc oxide | 53 | 1,383 | £178 | +156.2% ▲ |
| Enalapril maleate | 53 | 3,201 | £84 | -70.5% ▼ |
| Lorazepam | 53 | 1,390 | £495 | -62.8% ▼ |
| Amorolfine hydrochloride | 53 | 480 | £604 | +129.5% ▲ |
| Midazolam hydrochloride | 53 | 412 | £261 | +29.5% ▲ |
| Flecainide acetate | 51 | 5,214 | £206 | -34.7% ▼ |
| Pseudoephedrine hydrochloride | 51 | 1,700 | £312 | +879.3% ▲ |
| Ondansetron hydrochloride | 51 | 2,656 | £1.1K | +5.1% ▲ |
| 51 | 740 | £2.4K | +66.0% ▲ | |
| Sulfasalazine | 50 | 10.1K | £1.7K | -61.6% ▼ |
| Levomepromazine hydrochloride | 50 | 464 | £877 | +117.2% ▲ |
| Metronidazole | 50 | 943 | £140 | -23.9% ▼ |
| Mefenamic acid | 50 | 2,986 | £597 | +10.7% ▲ |
| Dosulepin hydrochloride | 49 | 2,134 | £432 | -13.4% ▼ |
| Ivermectin | 49 | 2,475 | £1.4K | +130.5% ▲ |
| Disulfiram | 48 | 672 | £2.3K | +224.2% ▲ |
| Timolol | 48 | 1,350 | £357 | -45.7% ▼ |
| Adapalene | 47 | 2,115 | £734 | +114.7% ▲ |
| 47 | 48 | £289 | -8.4% ▼ | |
| Valsartan | 46 | 2,436 | £605 | -21.9% ▼ |
| Terbutaline sulphate | 46 | 64 | £505 | -15.2% ▼ |
| Hydrocortisone | 46 | 6,152 | £1.4K | -45.5% ▼ |
| Water for injection | 46 | 579 | £171 | +36.0% ▲ |
| 46 | 2,423 | £4.7K | +36.2% ▲ | |
| 46 | 1,370 | £6.8K | +106.2% ▲ | |
| Sennosides | 45 | 13.2K | £245 | +45.7% ▲ |
| Exemestane | 45 | 626 | £122 | +38.5% ▲ |
| 45 | 5,900 | £247 | -65.7% ▼ | |
| 45 | 8,035 | £393 | -55.7% ▼ | |
| 44 | 46 | £108 | +35.8% ▲ | |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 43 | 37.6K | £1.2K | +283.5% ▲ |
| 43 | 789 | £872 | +77.5% ▲ | |
| 43 | 570 | £1.0K | +31.0% ▲ | |
| Powder extensively hydrolysed formula (0913101) | 42 | 89.2K | £2.6K | -41.7% ▼ |
| 42 | 1,955 | £282 | +56.4% ▲ | |
| Cimetidine | 41 | 6,056 | £818 | +119.8% ▲ |
| Metoclopramide hydrochloride | 41 | 4,810 | £320 | -50.5% ▼ |
| Biphasic insulin aspart | 41 | 240 | £1.4K | -59.6% ▼ |
| 41 | 6,201 | £340 | -85.2% ▼ | |
| Temazepam | 40 | 1,398 | £1.2K | -30.1% ▼ |
| Betamethasone sodium phosphate | 40 | 580 | £174 | +54.4% ▲ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 40 | 3,283 | £429 | +361.1% ▲ |
| Biphasic insulin lispro | 39 | 455 | £2.7K | -9.2% ▼ |
| Sodium fluoride | 39 | 4,077 | £464 | +17.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.